Skip to main content
PBYI logo
PBYI
(NASDAQ)
Puma Biotechnology, Inc.
$9.05-- (--)
Loading... - Market loading

Puma Biotechnology (PBYI) Stock Price & Financial Analysis

Puma Biotechnology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$9.01 - $9.45
52-Week High$9.74
52-Week Low$4.30
Open$9.31
Volume453.58K
Average Volume (3M)319.37K
Market Cap460.15M
Shares Outstanding50.85M
P/E Ratio (TTM)18.87
Forward P/E29.47
Price to Sales (P/S)2.03
Price to Book (P/B)3.58
EV/EBITDA9.80
Revenue (TTM)227.18M
Net Income (TTM)24.38M
Free Cash Flow (TTM)53.60M
EPS (TTM)$0.48
Profit Margin10.73%
Operating Margin12.98%
Return on Equity (ROE)18.99%
Debt to Equity0.12
50-Day MA$8.57
200-Day MA$7.11
52-Week Change92.14%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Puma Biotechnology

What is the current stock price for PBYI?

As of the latest trading session, PBYI stock trades at $9.05. The 52-week range is $4.30–$9.74, with a day range of $9.01–$9.45.

What is the P/E ratio for PBYI?

Puma Biotechnology's trailing P/E ratio is 18.9, meaning investors pay $18.9 for every $1 of annual earnings. The forward P/E is 29.5, reflecting analyst expectations for future earnings. Puma Biotechnology operates in the Healthcare sector.

Does PBYI pay dividends?

Puma Biotechnology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PBYI?

Based on 1 analyst, the consensus for PBYI is Buy.

What is the market cap of PBYI?

Puma Biotechnology's market capitalization is $460.1M, classifying it as a small-cap company. Puma Biotechnology operates in the Healthcare sector within the Biotechnology industry.